RT @oforrr: @ChatoGorordo @CochraneMexico al no ser estadísticamente significativa asumimos que los resultados eran homogéneos. Por lo tant…
@ChatoGorordo @CochraneMexico al no ser estadísticamente significativa asumimos que los resultados eran homogéneos. Por lo tanto el tratamiento ambulatorio de los pacientes con nyf es igual en su casa que en el hospital. https://t.co/VH074Z9mS2
@ChatoGorordo En nuestro meta-análisis @CochraneMexico https://t.co/VH074Z9mS2 sobre a eficacia del tratamiento ambulatorio de pacientes con neutropenia y fiebre, usamos la Tau que es una prueba similar a las Q de Cohcrane. https://t.co/PEW06vZLpm
RT @Cochrane_GNOCG: On the 18th day of advent …. https://t.co/wOxEMrP5Oi Bringing you a run-down of our 2019 reviews & protocols in our Co…
RT @Cochrane_GNOCG: On the 18th day of advent …. https://t.co/wOxEMrP5Oi Bringing you a run-down of our 2019 reviews & protocols in our Co…
RT @Cochrane_GNOCG: On the 18th day of advent …. https://t.co/wOxEMrP5Oi Bringing you a run-down of our 2019 reviews & protocols in our Co…
On the 18th day of advent …. https://t.co/wOxEMrP5Oi Bringing you a run-down of our 2019 reviews & protocols in our Cochrane GNOC evidence advent calendar…… #CGNOCadvent19 @CochraneLibrary @CochraneUK @cochranecollab https://t.co/FdeTqTgkr9
RT @Actual_clinica: El tratamiento ambulatorio para el paciente con cáncer que presenta un evento neutropénico febril de bajo riesgo es efe…
El tratamiento ambulatorio para el paciente con cáncer que presenta un evento neutropénico febril de bajo riesgo es efectivo Cochrane https://t.co/AsIk3VjyL4
RT @Cochrane_GNOCG: More research needed for outpatient treatment for people with cancer who develop a low‐risk febrile neutropaenic event…
More research needed for outpatient treatment for people with cancer who develop a low‐risk febrile neutropaenic event https://t.co/fdpaIolVwX @CochraneLibrary
RT @jhorcajada: Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. - PubMed - NCBI Cochrane Rev…
RT @jhorcajada: Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. - PubMed - NCBI Cochrane Rev…
RT @jhorcajada: Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. - PubMed - NCBI Cochrane Rev…
RT @jhorcajada: Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. - PubMed - NCBI Cochrane Rev…
Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. - PubMed - NCBI Cochrane Review https://t.co/oobXyQYM5H
RT @ChristieLibrary: Outpatient treatment for low‐risk febrile #neutropaenia in people with #cancer probably makes little difference to tre…
Outpatient treatment for low‐risk febrile #neutropaenia in people with #cancer probably makes little difference to treatment failure & mortality compared with the standard inpatient treatment &may reduce treatment time. @CochraneLibrary https://t.c
Outpatient treatment for people with cancer who develop a low‐risk febrile #neutropaenic event https://t.co/fCNUjcpfbO #cancer
Vamos a leer doctor. Saludos maestro...
Outpatient treatment for people with cancer who develop a low‐risk febrile neutropaenic event - Rivas‐Ruiz, R - 2019 | Cochrane Library https://t.co/2GZmIZJChb